Lifecome Biochemistry Co Ltd (002868) — Net Asset Quality Index
Lifecome Biochemistry Co Ltd (002868) has a Net Asset Quality Index of 9.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥773.72 Million minus total liabilities of CN¥702.61 Million yields net assets of CN¥71.11 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Lifecome Biochemistry Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Lifecome Biochemistry Co Ltd Net Asset Quality Index Over Time (2012–2025)
This chart shows how Lifecome Biochemistry Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 9.2%, representing net assets of CN¥71.11 Million against total assets of CN¥773.72 Million CNY. See Lifecome Biochemistry Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Lifecome Biochemistry Co Ltd (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Lifecome Biochemistry Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Lifecome Biochemistry Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 8.7% | CN¥64.93 Million | CN¥748.71 Million | CN¥683.78 Million | ▲ +10.3 pp |
| 2024 | -1.6% | CN¥-24.54 Million | CN¥1.49 Billion | CN¥1.52 Billion | ▼ -22.7 pp |
| 2023 | 21.1% | CN¥414.11 Million | CN¥1.97 Billion | CN¥1.55 Billion | ▼ -27.3 pp |
| 2022 | 48.3% | CN¥599.30 Million | CN¥1.24 Billion | CN¥640.56 Million | ▼ -9.0 pp |
| 2021 | 57.4% | CN¥722.02 Million | CN¥1.26 Billion | CN¥536.38 Million | ▼ -21.8 pp |
| 2020 | 79.2% | CN¥769.94 Million | CN¥972.50 Million | CN¥202.56 Million | ▲ +2.1 pp |
| 2019 | 77.1% | CN¥778.50 Million | CN¥1.01 Billion | CN¥231.55 Million | ▼ -15.2 pp |
| 2018 | 92.3% | CN¥740.37 Million | CN¥802.42 Million | CN¥62.05 Million | ▲ +0.3 pp |
| 2017 | 92.0% | CN¥695.68 Million | CN¥756.25 Million | CN¥60.56 Million | ▲ +18.8 pp |
| 2016 | 73.2% | CN¥271.34 Million | CN¥370.66 Million | CN¥99.32 Million | ▲ +12.3 pp |
| 2015 | 60.9% | CN¥238.98 Million | CN¥392.52 Million | CN¥153.54 Million | ▲ +12.0 pp |
| 2014 | 48.9% | CN¥190.87 Million | CN¥390.09 Million | CN¥199.22 Million | ▲ +6.1 pp |
| 2013 | 42.8% | CN¥169.42 Million | CN¥395.88 Million | CN¥226.45 Million | ▲ +0.7 pp |
| 2012 | 42.1% | CN¥156.45 Million | CN¥371.37 Million | CN¥214.92 Million | — |